| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |